Bluefin Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,024	Closed	-$310K	–	483
2020 Q4	$310K	Buy	+2,024	New	+$310K	0.02%	299